BodylogicalⓇ gives more power to consumers to do more with their health

Overview

Too often, the effectiveness of fitness trackers drops off because there’s not enough insight and personal value in the information being collected, and; people often stick to doctor’s orders for a short amount of time and then slide back into their usual habits, often causing chronic conditions to worsen. 

How can we make managing health sticky? By putting the strength of Bodylogical’s prescriptive analytics directly into the hands of the individual health consumer. 

A 'digital twin' that models the human body and uses data to predict the health of 'future you'

Bodylogical will have major implications for the entire healthcare system - pharma, payers, providers and patients, and this study shows that it works. 

For pharmaceutical companies, it creates possibilities for faster, better targeted, and less expensive clinical trials, accelerating drugs to market and ultimately improving healthcare outcomes.

Payers and providers can use Bodylogical to see the future at an individual level guiding treatment of patients, and to better manage chronic diseases across patient populations.

Results from PwC’s BodylogicalⓇ tool have been validated by a leading peer-reviewed scientific journal.